About: Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific journal article

Attributes	Values
rdf:type	Item
description	artículu científicu espublizáu en 1999 (ast) vědecký článek publikovaný v roce 1999 (cs) наукова стаття, опублікована в червні 1999 (uk) مقالة علمية (نشرت في يونيو 1999) (ar) vedecký článok (publikovaný 1999/06/01) (sk) 1999 թուականի Յունիսին հրատարակուած գիտական յօդուած (hyw) 1999 թվականի հունիսին հրատարակված գիտական հոդված (hy) wetenschappelijk artikel (gepubliceerd op 1999/06/01) (nl) im Juni 1999 veröffentlichter wissenschaftlicher Artikel (de) scientific journal article (en)
publication date	wds:Q28609380-F05B92ED-CC2E-4BFF-9AFF-FE4F38569285
publication date	1999-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q28609380-87AB9BE3-371E-4C7B-A2F1-361D62DF66D8
language of work or name	English
author name string	wds:Q28609380-0FBD8D37-E272-44AC-A9E2-20DD1192670A wds:Q28609380-5E6E5438-47A5-4C66-B31F-F005B3C2BF66 wds:Q28609380-973AB6C0-DF5A-484E-87D6-F51BD985E242 wds:Q28609380-A1FCF5BC-2CDD-46F4-B1B6-49753833AC69 wds:Q28609380-C320146E-67E3-4040-A5F5-5DAF032BB1EC wds:Q28609380-C7503803-AC12-423C-82B3-BDB744C259AE wds:Q28609380-DFCD5990-FE59-434B-AF1A-02963D38A00A
OpenCitations bibliographic resource ID	wds:Q28609380-2DDB3A58-2879-4200-91CA-D5B0E87BCCDE
OpenCitations bibliographic resource ID	https://w3id.org/oc/corpus/br/4796372
author name string	Upton M Small EJ Balk SP Ko YJ Taplin ME Bubley GJ Rajeshkumar B
OpenCitations bibliographic resource ID	4796372
rdfs:label	Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist (en) Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist (nl) Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist (ast)
skos:prefLabel	Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist (en) Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist (nl) Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist (ast)
name	Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist (en) Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist (nl) Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist (ast)
title	wds:Q28609380-31B027D6-CE27-4B28-A25A-C965CEDDAABE
title	Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist (en)
page(s)	wds:Q28609380-47306295-1F61-4B1D-8AAF-A025F1B7C909
page(s)	2511-2515
instance of	wds:Q28609380-77B8825D-A727-407F-A62D-D6C2AE463E93
instance of	scholarly article
main subject	wds:Q28609380-3601EB5C-88B0-425F-B9A3-FA6BF7845C9F
main subject	prostate cancer
PubMed ID	wds:Q28609380-9B9A1381-D01A-429C-8DFF-816AA23927C7
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10363963
PubMed ID	10363963
published in	wds:Q28609380-AD23BB12-A62C-491C-B42D-DEFB0E00DA1F
published in	Cancer Research
issue	wds:Q28609380-EB37122B-3621-425E-B21F-7B442565ACDB
volume	wds:Q28609380-298F48EC-877B-492C-94F9-1934BA13BA57
issue	11
volume	59
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q28609380
is cites work of	Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity. Molecular pathways: Inhibiting steroid biosynthesis in prostate cancer Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR). The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer Androgen action and metabolism in prostate cancer Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer In silico discovery of androgen receptor antagonists with activity in castration resistant prostate cancer Biomarker-based targeting of the androgen-androgen receptor axis in advanced prostate cancer Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone The complex interplay between cholesterol and prostate malignancy Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors Myc confers androgen-independent prostate cancer cell growth Androgen-independent prostate cancer: potential role of androgen and ErbB receptor signal transduction crosstalk Diastereomers of the brominated flame retardant 1,2-dibromo-4-(1,2 dibromoethyl)cyclohexane induce androgen receptor activation in the hepg2 hepatocellular carcinoma cell line and the lncap prostate cancer cell line Mechanisms mediating androgen receptor reactivation after castration Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis Androgen receptor gene mutation, rearrangement, polymorphism. Mutation of the androgen receptor causes oncogenic transformation of the prostate AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivo Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors Molecular pathology of prostate cancer revealed by next-generation sequencing: opportunities for genome-based personalized therapy Identification of androgen-coregulated protein networks from the microsomes of human prostate cancer cells Androgen regulation of the androgen receptor coregulators Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer. Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer Mechanisms of drug resistance that target the androgen axis in castration resistant prostate cancer (CRPC). The biology of castration-resistant prostate cancer Mechanisms of the development of androgen independence in prostate cancer Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult The complexity of prostate cancer: genomic alterations and heterogeneity. The isolation and identification of apolipoprotein C-I in hormone-refractory prostate cancer using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software